论文部分内容阅读
目的:探讨支气管哮喘患者采用沙美特罗替卡松粉吸入剂治疗的临床效果。方法:本次研究选择的对象共80例,均为我院2009年2月至2010年2月收治的支气管哮喘患者,随机分组,观察组40例采用沙美特罗替卡松粉吸入剂治疗,对照组40例采用必可酮气雾剂治疗,回顾两组临床资料。结果:观察组40例患者中,临床总有效率为97.5%,对照组40例患者中,临床总有效率为85%,观察组显著高于对照组(P<0.05)。观察组声嘶、皮疹、口咽部刺激等不良反应率与对照组比较无明显差异(P>0.05)。结论:支气管哮喘患者采用沙美特罗替长松粉吸入剂治疗,可显著提高临床效果,有效避免不良反应发生,使患者预后得到明显改善,具有非常积极的临床意义。
Objective: To investigate the clinical effect of salmeterol and fluticasone inhalation in patients with bronchial asthma. Methods: A total of 80 subjects selected in this study were all patients with bronchial asthma admitted from February 2009 to February 2010 in our hospital. Patients in the observation group were treated with salmeterol and fluticasone propionate inhalation, In the control group, 40 patients were treated with beclomethasone aerosol, and the clinical data of two groups were reviewed. Results: Among the 40 patients in the observation group, the total clinical effective rate was 97.5%. Among the 40 patients in the control group, the total clinical effective rate was 85%. The observation group was significantly higher than the control group (P <0.05). There was no significant difference between the observation group and the control group (P> 0.05), such as hoarseness, rash and oropharyngeal irritation. Conclusion: Salmeterol inhalation for long asthma treatment for patients with bronchial asthma can significantly improve the clinical efficacy, effectively prevent adverse reactions, so that patients with significantly improved prognosis, has a very positive clinical significance.